Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A severe combined immunodeficiency characterized by congenital alopecia, severe T-cell immunodeficiency, and ridging, pitting or curving of all nails that has material basis in homozygous mutation in the FOXN1 gene on chromosome 17q11-q12.
Features include: Decreased total T cell count, Alopecia, Ridged nail, and Severe T-cell immunodeficiency and 3 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 4 | Alopecia, Ridged nail, Nail pits |
Blood and immune system | 1 | Severe T-cell immunodeficiency |
Age of onset: at birth.
FOXN1 encodes forkhead box N1 (648 aa). Transcriptional regulator which regulates the development, differentiation, and function of thymic epithelial cells (TECs) both in the prenatal and postnatal thymus. Highest expression in Skin Sun Exposed Lower leg (64.3 TPM) and Skin Not Sun Exposed Suprapubic (58.3 TPM).
T-cell immunodeficiency, congenital alopecia, and nail dystrophy is caused by mutations in the FOXN1 gene on chromosome 17.
FOXN1 is classified as a druggable target (Kinase and Transcription Factor categories) with score 0.0.
Genetic testing for FOXN1 is available. Testing is considered confirmatory for diagnosis.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for T-cell immunodeficiency, congenital alopecia, and nail dystrophy.
20 publications have been identified in PubMed for T-cell immunodeficiency, congenital alopecia, and nail dystrophy. Research spans Case Report / Case Series (35%), Basic Science / Preclinical (25%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 35% |
Laboratory research | 5 | 25% |
Research summaries | 3 | 15% |
Other research | 2 | 10% |
Clinical study results | 2 | 10% |
Disease patterns and progression | 1 | 5% |
Yılmaz BC (2026). [PMID: 41738375](https://pubmed.ncbi.nlm.nih.gov/41738375/). *Immunity, inflammation and disease*. [Epidemiology / Natural History]
Ogunsola HY (2026). [PMID: 41502238](https://pubmed.ncbi.nlm.nih.gov/41502238/). *Expert Rev Mol Med*. [Review / Meta-Analysis]
Hanan A (2025). [PMID: 40625686](https://pubmed.ncbi.nlm.nih.gov/40625686/). *Case reports in dermatology*. [Case Report / Case Series]
Wysocki CA (2025). [PMID: 40484290](https://pubmed.ncbi.nlm.nih.gov/40484290/). *The Journal of allergy and clinical immunology*. [Review / Meta-Analysis]
Acar A (2025). [PMID: 40465559](https://pubmed.ncbi.nlm.nih.gov/40465559/). *Cutaneous and ocular toxicology*. [Review / Meta-Analysis]
Vaidya T (2025). [PMID: 39901443](https://pubmed.ncbi.nlm.nih.gov/39901443/). *International journal of STD & AIDS*. [Clinical Trial Publication]
Udemgba C (2025). [PMID: 40090425](https://pubmed.ncbi.nlm.nih.gov/40090425/). *The Journal of allergy and clinical immunology*. [Basic Science / Preclinical]
Hardy Q (2025). [PMID: 40829354](https://pubmed.ncbi.nlm.nih.gov/40829354/). *Annales de dermatologie et de venereologie*. [Clinical Trial Publication]
Unknown (2025). [PMID: 41061036](https://pubmed.ncbi.nlm.nih.gov/41061036/). *Clin Exp Dermatol*. [Other]
Gold M (2025). [PMID: 41148944](https://pubmed.ncbi.nlm.nih.gov/41148944/). *Hematology reports*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 5:38 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about T-cell immunodeficiency, congenital alopecia, and nail dystrophy